There are many processes in which the neuropeptide nociceptin/orphanin FQ (N/OFQ or nociceptin) is involved in the brain. The role of nociceptin in learning and memory holds promise in modulating these processes in health and disease in the human brain. This review summarizes the body of research focused on N/OFQ and its specific receptor, the nociceptin receptor (NOP receptor), in learning and memory, and its potential mechanisms of action, in which acetylcholine, NMDA receptor, and noradrenaline may be critical. Finally, the association between NOP receptor and posttraumatic stress disorder (PTSD), a psychiatric disorder with altered fear learning, is examined as one of the potential outcomes resulting from pathological consequences of dysregulation of N/OFQ-NOP receptor in the brain.
Introduction
Nociceptin receptor (NOP receptor) (Mollereau et al., 1994) , encoded by the gene Opioid receptor-like 1 (Oprl1), is a G protein-coupled receptor, and the last discovered member of the opioid family. Its specific endogenous agonist was named nociceptin/orphanin FQ (N/OFQ). The term nociceptin comes from one of the first physiological actions shown for this peptide which was pronociceptive (Meunier et al., 1995) . Civelli's group also reported that the same peptide, which they called Orphanin FQ, was a heptadecapeptide (FGGFTGARKSARKLANQ) that activated the NOP receptor (Reinscheid et al., 1995) . Similar to other opioid peptides, N/OFQ is synthesized from a precursor protein, PreproN/OFQ (encoded by the prepronociceptin gene, Pnoc) (Saito et al., 1995) . N/OFQ is homologous with the opioid peptides, but it does not bind to the opioid receptors (Meunier, 1997) . At a genetic level, NOP receptor belongs to the opioid family for its similarity. However, opioid ligands do not bind with high affinity to NOP receptor and this is why it was called the "orphan" opioid receptor.
N/OFQ-NOP receptors are abundantly expressed in the central nervous system and peripheral organs, having different roles in several functions such as stress, immunology, depression, cardiovascular responses, drug abuse, and anxiety (Bodnar, 2013; Gavioli and Calo, 
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